Clinical Evaluation of a Newly Designed Compliant Side Port Catheter for an Insulin Implantable Pump

Authors:
  • EGEVADIAC Study Group
    EVADIAC Study Group

Abstract
The EVADIAC Group designed a study protocol to investigate the effect of this new side port catheter on the stability of insulin delivery and to assess the clinical improvement of the catheter compliance. After the approval of an ethical committee, 40 type 1 diabetic patients, currently implanted, were consecutively enrolled for a new implantation with the Minimed implantable pump MMT 2001 and the modified side port catheter MMT 4027 (Minimed). The patients were seen every 45 days to refill the pump reservoirs, to examine the accuracy of the insulin delivery system, to measure the HbA1c levels, and to check for adverse events. The main end point was the accuracy of insulin infusion (% error), calculated from the ratio of the difference between the programmed and the actual infused insulin volume on programmed insulin delivery.